杜比实验室 2024年度报告

Washington, D.C. 20549FORM10-K ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year EndedSeptember 26, 2025ORTRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Transition Period FromToCommission File Number:001-32431 DOLBY LABORATORIES, INC. (Exact name of registrant as specified in its charter) 90-0199783(I.R.S. Employer Identification No.) Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.YesýNo Indicate by check mark if the registrant is not required to file reports pursuant to Section13 or Section15(d) of the Act. Yes¨Noý Indicate by check mark whether the registrant (1)has filed all reports required to be filed by Section13 or 15(d) of the Securities Exchange Act of 1934during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2)has been subject to such filingrequirements for the past 90days.YesýNo¨ Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 ofRegulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit suchfiles).YesýNo¨ Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or anemerging growth company.See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company," and "emerging growthcompany" in Rule 12b-2 of the Exchange Act. Large accelerated filer☒Accelerated filer☐Non-accelerated filer☐Smaller reporting company☐Emerging growth company☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any newor revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.¨ Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internalcontrol over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that☒ If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statementsof the registrant included in the filing reflect the correction of an error to previously issued financial statements.☐Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensationreceived by any of the registrant’s executive officers during the relevant recovery period pursuant to §240.10D-1(b).☐Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act).Yes☐No☒ The aggregate market value of the voting common equity held by non-affiliates of the registrant as of March28, 2025was $3.0billion. This calculation excludes the shares of ClassA and Class B common stock held by executive officers, directors and stockholderswhose combined ownership of Class A and Class B common stock exceeds 5% of the shares of Class A common stock outstanding as of March28,2025. This calculation does not reflect a determination that such persons are affiliates for any other purposes. On October24, 2025, the registrant had60,845,846shares of ClassA common stock, par value $0.001 per share, and34,660,045shares of Class B common stock, par value $0.001 per share, outstanding. DOCUMENTS INCORPORATED BY REFERENCE Portions of the registrant’s Definitive Proxy Statement to be filed with the Commission pursuant to Regulation 14A in connectionwith the registrant’s 2026 Annual Meeting of Stockholders, to be filed subsequent to the date hereof, are incorporated by reference intoPart III of this Report. Such Definitive Proxy Statement will be filed with the Securities and Exchange Commission not later than 120days after the conclusion of the registrant’s fiscal year ended September26, 2025. Except with respect to information specificallyincorporated by reference in this Form 10-K, the Definitive Proxy Statement is not deemed to be filed as part of this Form 10-K. DOLBY LABORATORIES, INC.FORM 10-KFor the Fiscal Year Ended September26, 2025TABLE OF CONTENTS PARTI Item 1—BusinessItem 1A—Risk FactorsItem 1B—Unresolved Staff CommentsItem 1C—CybersecurityItem2—PropertiesItem3—Legal ProceedingsItem4—Mine Safety Disclosures PART II Item5—Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases ofEquity SecuritiesItem6—[Reserved]Item7—Management’s Discussion and Analysis of Financial Condition and Results of OperationsItem7A—Quantitative and Qualitative Disclosures About Market RiskItem8—ConsolidatedFinancial StatementsItem9—Changes